← Browse by Condition
Medical Condition

cd7 t all lbl

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT07280494 Phase 1
Recruiting

To Observe the CD7-targeted CAR-T Therapy in the Treatment of MRD Positive T-ALL/LBL Post Allo-HSCT

Enrollment
18 pts
Location
China
Sponsor
Peking University People's Hos...
View Trial →